Editorial: γδ T Cells in Cancer

Seth B. Coffelt; Dieter Kabelitz; Bruno Silva-Santos; Jurgen Kuball; Willi Born; Ilan Bank

doi:10.3389/fimmu.2020.602411

Editorial: γδ T Cells in Cancer

Seth B. Coffelt^*, Dieter Kabelitz, Bruno Silva-Santos, Jurgen Kuball, Willi Born, Ilan Bank

^*Corresponding author for this work

Research output: Contribution to journal › Editorial

Original language	English
Article number	602411
Journal	Frontiers in Immunology
Volume	11
DOIs	https://doi.org/10.3389/fimmu.2020.602411
State	Published - 20 Nov 2020
Externally published	Yes

Keywords

bisphoshonates
butyrophilin
cancer
immunotherapy
γδ T cells

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fimmu.2020.602411

Cite this

@article{ac0c748e891e4362928785ed39a57616,

title = "Editorial: γδ T Cells in Cancer",

keywords = "bisphoshonates, butyrophilin, cancer, immunotherapy, γδ T cells",

author = "Coffelt, {Seth B.} and Dieter Kabelitz and Bruno Silva-Santos and Jurgen Kuball and Willi Born and Ilan Bank",

note = "Funding Information: The authors acknowledge funding from the Cancer Research UK Glasgow Centre (A25142 to SBC), the Wellcome Trust (208990/ Z/17/Z to SBC), the Medical Research Council (MR/R502327/1 to SBC), Breast Cancer Now (2018JulPR1101 and 2019DecPhD1349 to SBC), Tenovus Scotland (S17-17 to SBC), the Deutsche Forschungsgemeinschaft (Ka 502/19-2 to DK), the Wilhelm Sander Foundation (2018.045.1 to DK), “la Caixa” Banking Foundation (HR18-00069 to BS-S), the Dutch Research Council (NWO ZonMW 43400003 to JK), the Dutch Cancer Society (KWF UU 2014-6790, UU 2015-7601, UU 2018-11393, UU 2018-11979, UU 2019-12586, UU 2020-13043 to JK).",

year = "2020",

month = nov,

day = "20",

doi = "10.3389/fimmu.2020.602411",

language = "אנגלית",

volume = "11",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Editorial

T2 - γδ T Cells in Cancer

AU - Coffelt, Seth B.

AU - Kabelitz, Dieter

AU - Silva-Santos, Bruno

AU - Kuball, Jurgen

AU - Born, Willi

AU - Bank, Ilan

N1 - Funding Information: The authors acknowledge funding from the Cancer Research UK Glasgow Centre (A25142 to SBC), the Wellcome Trust (208990/ Z/17/Z to SBC), the Medical Research Council (MR/R502327/1 to SBC), Breast Cancer Now (2018JulPR1101 and 2019DecPhD1349 to SBC), Tenovus Scotland (S17-17 to SBC), the Deutsche Forschungsgemeinschaft (Ka 502/19-2 to DK), the Wilhelm Sander Foundation (2018.045.1 to DK), “la Caixa” Banking Foundation (HR18-00069 to BS-S), the Dutch Research Council (NWO ZonMW 43400003 to JK), the Dutch Cancer Society (KWF UU 2014-6790, UU 2015-7601, UU 2018-11393, UU 2018-11979, UU 2019-12586, UU 2020-13043 to JK).

PY - 2020/11/20

Y1 - 2020/11/20

KW - bisphoshonates

KW - butyrophilin

KW - cancer

KW - immunotherapy

KW - γδ T cells

UR - http://www.scopus.com/inward/record.url?scp=85097285842&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2020.602411

DO - 10.3389/fimmu.2020.602411

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???

C2 - 33329597

AN - SCOPUS:85097285842

SN - 1664-3224

VL - 11

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 602411

ER -

Editorial: γδ T Cells in Cancer

Keywords

UN SDGs

Access to Document

Other files and links

Cite this